Skip to main content


Figure 1 | Lipids in Health and Disease

Figure 1

From: Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study

Figure 1

Changes in total plasma cholesterol (CH; -0.2%; p = 0.76), low density lipoproteins (LDL; +6.1%; p = 0.08), triglycerides (TG; -29.8%; p = 0.24), and high density lipoproteins (HDL; +29.7%; p = 0.000003), resulting from oral administration of V-6 as evaluated by repeated measure ANOVA. Individual values from each of 12 patients, collected through weeks 2, 4, and 8, are plotted and mean values are shown in each graph in bold.

Back to article page